Kruxade

Amoxicillin, the active ingredient in Kruxade, is a Penicillin (beta-lactam) with beta‑lactamase inhibitor presented as an oral tablet for systemic use. It treats bacterial infections such as acute sinusitis, community‑acquired pneumonia, acute otitis media, uncomplicated urinary tract infections and skin and soft‑tissue infections in adults and children.

GNH USA supplies Kruxade as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kruxade is an oral antibacterial that targets a broad range of bacterial pathogens in common infections. - Acute sinusitis: reduces symptoms and clears the infection. - Community‑acquired pneumonia: provides effective bacterial eradication. - Acute otitis media: relieves ear pain and eliminates causative organisms. - Uncomplicated urinary tract infections: resolves urinary symptoms and bacterial load. - Skin and soft‑tissue infections: treats cellulitis and related bacterial skin conditions.

Adverse reactions may occur with any antibiotic and should be monitored.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: increased bowel movements, sometimes loose. - Rash: skin redness or itching. - Vomiting: occasional emesis. - Abdominal pain: cramping or discomfort. - Headache: transient mild headache.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring emergency care. - Clostridioides difficile‑associated diarrhea: severe colitis. - Liver enzyme elevation: signs of hepatic stress. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction. - Neutropenia: reduced white blood cell count. - Hemolytic anemia: destruction of red blood cells.

Use Kruxade only under medical supervision and consider the following precautions. - Allergy assessment: confirm no known penicillin or beta‑lactamase inhibitor allergy. - Renal function: adjust dose in patients with impaired kidney function. - Hepatic monitoring: observe liver function during prolonged therapy. - Pregnancy safety: use only if clearly needed; data are limited. - Concomitant beta‑lactam allergy: avoid in patients with documented hypersensitivity. - Store at ambient temperature: keep in the original pack, protect from moisture.

Kruxade may interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Probenecid: increases amoxicillin plasma levels, risking toxicity. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Methotrexate: can raise methotrexate concentrations, leading to toxicity.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce efficacy, consider backup contraception. - Allopurinol: increased risk of rash. - Diuretics (e.g., furosemide): may cause potassium loss. - Antacids containing aluminum or magnesium: can reduce amoxicillin absorption.